Aimei Health Technology Co., Ltd.

Aimei Health Technology Co., Ltd., trading under the ticker AFJK on Nasdaq, is a blank check company formed to pursue a business combination in the health technology sector, with a focus on opportunities in Asia. The company filed an amended registration statement (S-1/A) with the Securities and Exchange Commission on July 24, 2023, under accession number 0001493152-23-025299, reflecting updates to its offering documents as part of the IPO process. Aimei Health Technology operates in the healthcare and life sciences SPAC space, a segment that drew significant sponsor interest in the early-to-mid 2020s. Visit SpacDesk and sign up for full data, filings history, and deal status updates on AFJK and hundreds of other active and completed SPAC transactions.